Matthew J. Budoff MDProgram Director, Division of Cardiovascular Medicine, Professor of Medicine, the David Geffen School of Medicine at UCLA, Los Angeles, California
Dr. Matthew Budoff is at the forefront of the medical community’s efforts to develop early detection methods for cardiac disease, the number one cause of death in the U.S. Given that approximately 50 percent of U.S. heart disease victims learn of their illness by experiencing a sometimes fatal heart attack, Dr. Budoff has devoted much of his time over the past 20 years to advancing procedures that can help doctors identify cardiac patients early, and place them on a therapeutic path to prevent a heart attack.
Dr. Budoff works on at least 20 active medical research trials at any given time, and is a frequent lecturer on topics of cardiology at symposia, congresses and annual conferences on every continent. He has authored or co-authored over 600 research papers, six books, and 36 book chapters.
In the past two years alone, Dr. Budoff has been honored with multiple awards recognizing his professional skills and accomplishments. Of particular note is his receipt of the Einstein Award for Scientific Achievement from the International Biographical Centre, Cambridge, U.K.; his inclusion in five respected lists of top doctors in America; being named to the US News list of Top Doctors for 2011; and, most recently, named to “Worlds Most Influential Scientific Minds” in 2014.
Dr. Budoff graduated cum laude from the University of California, Riverside, with a major in biochemistry. He went on to graduate with distinction and a member of Alpha Omega Alpha from the George Washington University School of Medicine, in Washington, DC, before returning to his native California to complete an internship and residency in internal medicine, and a fellowship in cardiology, at Harbor-UCLA Medical Center in Torrance, where he currently acts as Program Director for the Cardiology Fellowship and Director of Cardiac Computed Tomography.
Recent Contributions to PracticeUpdate:
- High-Risk Coronary Plaque Regression After Intensive Lifestyle Intervention in Nonbstructive Coronary Disease
- Asymptomatic Left Ventricular Dysfunction in Type 2 Diabetics Without Known Cardiovascular Disease
- Nonculprit Lesion Plaque Morphology in Patients With STEMI
- Short-Term Progression of Multiterritorial Subclinical Atherosclerosis
- Plaque Morphology as Predictor of Late Plaque Events in Patients With Asymptomatic Type 2 Diabetes
- MY APPROACH to Interpreting Changes in Coronary Plaque Volume
- Plaque Quantification by Coronary CTA Using Intravascular Ultrasound as a Reference Standard
- Coronary Artery Calcium Score for Long-Term Risk Classification in Type 2 Diabetes
- Workstation-Based Calculation of CTA-Based FFR for Intermediate Stenosis
- MY APPROACH to Risk Assessment for Heart Disease in Asymptomatic Patients